Simplify device/formulation complexity with us
Our approach to combination product manufacturing is tailored specifically to design devices and processes that are friendly to sensitive protein formulations, biopharmaceuticals and specialized compounds.
We ensure the quality of your final product by selecting materials that are expected to minimize leachables and particles, and by reducing human intervention through an aseptic manufacturing line that is consistent from preparation and filling to assembly.
We offer parenteral drug developers more:
- Exclusive access to advanced to an integrated portfolio of combination parenteral drug delivery technologies
- A device engineering team that specializes in understanding challenges and resolving issues related to matching large, middle, and small molecule formulations to PFS, device, process and patient
-
A formulation team experienced in parenteral drug formulation development, technology transfer and regulatory filing
-
Sterile aseptic capacity with flexible capacities, automation and controls for all phases of clinical development and commercialization
-
A strategically located development and manufacturing partner with the regulatory experience to help launch products in markets all over the world faster and more successfully
In addition to continuous improvement to production systems to more efficiently match formulation characteristics and devices, we offers newly expanded production capacity across its three facilities in Japan, which are cGMP compliant and certified by PMDA as well as overseas regulatory authorities including the FDA and EMA.